company background image
JBCHEPHARM logo

J. B. Chemicals & Pharmaceuticals NSEI:JBCHEPHARM 株式レポート

最終価格

₹1.75k

時価総額

₹271.5b

7D

5.0%

1Y

25.6%

更新

26 Nov, 2024

データ

会社財務 +

J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM 株式レポート

時価総額:₹271.5b

JBCHEPHARM 株式概要

J.B.ケミカルズ&ファーマシューティカルズ・リミテッドは、医薬品製剤、ハーブ療法、原薬(API)の製造・販売をインド国内外で行っている。 詳細

JBCHEPHARM ファンダメンタル分析
スノーフレーク・スコア
評価2/6
将来の成長4/6
過去の実績5/6
財務の健全性6/6
配当金4/6

J. B. Chemicals & Pharmaceuticals Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめJ. B. Chemicals & Pharmaceuticals
過去の株価
現在の株価₹1,749.70
52週高値₹2,030.00
52週安値₹1,371.00
ベータ-0.016
11ヶ月の変化-7.52%
3ヶ月変化-11.14%
1年変化25.62%
33年間の変化113.55%
5年間の変化766.51%
IPOからの変化2,216.72%

最新ニュース

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Recent updates

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 27
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Sep 24
J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price

Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

Aug 15
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation

J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 11
J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

Jun 28
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Apr 19
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

株主還元

JBCHEPHARMIN PharmaceuticalsIN 市場
7D5.0%1.1%2.0%
1Y25.6%43.3%28.6%

業界別リターン: JBCHEPHARM過去 1 年間で43.3 % の収益を上げたIndian Pharmaceuticals業界を下回りました。

リターン対市場: JBCHEPHARMは、過去 1 年間で28.6 % のリターンを上げたIndian市場を下回りました。

価格変動

Is JBCHEPHARM's price volatile compared to industry and market?
JBCHEPHARM volatility
JBCHEPHARM Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

安定した株価: JBCHEPHARM過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: JBCHEPHARMの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19765,311Nikhil Choprawww.jbpharma.com

J.J. B. Chemicals & Pharmaceuticals Limited は、医薬品製剤、漢方薬、原薬(API)をインド国内外で製造・販売している。同社のAPI製品ポートフォリオには、ジクロフェナクナトリウム、ジエチルアミン、酸、カリウム、ニフェジピン、アテノロール、シルニジピン、シプロフロキサシン、セチリジン、メクリジンHCIなどがある。また、錠剤、トローチ剤、注射剤、ゲル剤、クリーム剤、軟膏剤、液体ハーブシロップ剤、コールドラブ剤、点眼剤、トローチ剤、カプセル剤などの剤形や、ソフトカプセル剤、粉末剤、薬用トローチ剤、ハーブトローチ剤など、さまざまな医薬品の剤形も提供している。さらに、X線、磁気共鳴画像装置(MRI)、超音波スキャナーなどの造影剤製品、製造受託サービスも提供している。同社は、消化器、抗感染症、創傷治療、新生児・小児科、婦人科、歯科、ビタミン・ミネラル、高血圧、糖尿病、腎臓、呼吸器、鎮痛、皮膚科、抗ウイルス剤、トローチ、造影剤、放射線診断の治療分野で製品を提供している。J B.ケミカルズ&ファーマシューティカルズ・リミテッドは1976年に設立され、インドのムンバイに本社を置いている。

J. B. Chemicals & Pharmaceuticals Limited 基礎のまとめ

J. B. Chemicals & Pharmaceuticals の収益と売上を時価総額と比較するとどうか。
JBCHEPHARM 基礎統計学
時価総額₹271.45b
収益(TTM)₹6.11b
売上高(TTM)₹37.11b

44.4x

PER(株価収益率

7.3x

P/Sレシオ

JBCHEPHARM は割高か?

公正価値と評価分析を参照

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
JBCHEPHARM 損益計算書(TTM)
収益₹37.11b
売上原価₹12.84b
売上総利益₹24.27b
その他の費用₹18.16b
収益₹6.11b

直近の収益報告

Sep 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)39.35
グロス・マージン65.40%
純利益率16.47%
有利子負債/自己資本比率2.5%

JBCHEPHARM の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

0.8%

現在の配当利回り

17%

配当性向